Synthesis of the Indole Metabolite Mimics FKK1-FKK9
Synthetic Procedures
Overview of the synthetic routes. The screened compounds are highlighted in blue (DMF -N,Ndimethyl formamide, THF = tetrahydrofurane, µw = microwave); initial synthetic targets in green, lead compounds in red. Interestingly, treatment with hydrochloric acid selectively removes the terminal ethyl ether from both EOM-protected indoles. The remaining hydroxymethyl groups can then be cleaved using lithium hydroxide in methanol (THF = tetrahydrofurane).
Synthesis of bis(1-(ethoxymethyl)-1H-indol-2-yl)(pyridin-4-yl)methanol (S1):
In a 10mL screwcap tube with stir bar and septum, 1-(ethoxymethyl)-1H-indole (53.7 mg, 0.306 mmol, 2.10 equiv) was dissolved in THF (0.50 mL) and cooled to -78 °C for 10 min. n-Butyllithium (0.200 mL, 0.320 mmol, 2.20 equiv) was added drop wise via syringe (reaction mixture turned yellow). The mixture was stirred for 1 h, at -78 °C, then warmed to 0 °C (mixture turned red). After stirring at 0 °C for over-all 0.5 h, the mixture was re-cooled to -78 °C. Methyl isonicotinate (20.0 mg, 0.146 mmol) was added neat (immediate color change to lighter red, then dark green), the mixture stirred at -78 °C for 5 min, then warmed to RT (color change to red after a while). TLC analysis of a reaction aliquot (satd. aq.
NH4Cl/EtOAc micro-workup) indicated full conversion after 0.5 h, at RT. Satd. aq. NH4Cl (1.0 mL) was added, followed by ethyl acetate (3.0 mL). The layers were thoroughly mixed, separated and the aqueous layer was extracted with EtOAc (2 ´ 2.0 mL). The combined organic layers were dried (MgSO4), filtered and evaporated in vacuo to obtain the product as orange oil. Chromatography (silica; 0®15 % EtOAc in hexane) afforded bis(1-(ethoxymethyl)-1H-indol-2-yl)(pyridin-4-yl)methanol (S1; 11.7 mg, 0.026 mmol, 18 %) as colorless resin that solidifies by time. Strong gas formation was observed, indicating deprotonation. After stirring the resulting, more and more viscous slurry for 10 min at 0 °C, the mixture was allowed to warm to RT and stirred at RT for 1.5 h. The mixture was cooled to 0 °C again, then (chloromethoxy)ethane (3.56 mL, 30.7 mmol, 1.20 equiv) was added neat over 10 min in small portions. Most of the material seems to dissolve.
The mixture was stirred at 0 °C and followed TLC analysis of reaction aliquots (micro-workup: satd.
aq. NH4Cl/EtOAc). After 3 h, complete conversion of the starting material was observed. 1 The milky reaction mixture was poured on 200 mL ice-cold satd. aq. NaHCO3. The mixture was transferred into a separatory funnel, extracted with ethyl acetate (300 mL in total). The organic layer was washed with satd. aq. sodium bicarbonate (100 mL), water (100 mL), satd. aq. NaHCO3 (100 mL), and brine (100 mL). The organic layer was dried (MgSO4), filtered and evaporated in vacuo to receive the crude product as pale yellow oil. Chromatography (silica; 0®15 % EtOAc in hexane) afforded 1-(ethoxymethyl)-1H-indole (3.17 g, 18.1 mmol, 71 %) as colorless oil. 1 In other runs, the mixture was stirred overnight, which turned out to be disadvantageous, as considerable decomposition was observed. It is hence recommended to follow the reaction closely and work up as soon as complete conversion is reached. 3 Two columns were required to reduce contamination with triphenylphospine oxide. Compounds were used in the next step if the purity was 95% or better as judged by 1 H-NMR. was used successfully to obtain 7b, which was subsequently cyclized using the same silver-catalyzed protocol as described above (µw = microwave) to obtain 8a. 
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Deprotecting the cyclization precursor S7a: A two-step deprotection similar to the one developed for S1 proved useful here. Nevertheless, the overall yield is low, with losses occurring mainly in the second step and probably during purification (TFA = trifluoroacetic acid). (1-(Phenylsulfonyl)-1H-indol-2-yl)-1-(pyridin-4-yl)but-2-yn-1-ol (S9b; FKK-3 
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Gram-Scale Synthesis of lead compounds FKK5 (S5b) and FKK6 (S6b)
Scheme 7: Improved synthesis of S5b and S6b: For a more efficient synthesis of the two lead compounds, the synthetic route was slightly modified. The addition of a lithium reagent, directly generated from S3b and n-BuLi, to the Weinreb amide of isonicotinic acid (S10) gave easy and scalable access to S5b in only one synthetic step, starting exclusively from commercially available starting materials and reagents. The previously utilized addition of a propargylic Grignard reagent to S5b proved scalable and delivered S6b in excellent yield. X-ray Analysis. Single crystals of FKK5 and FKK6, respectively, were submitted for X-ray diffraction analysis. The data were collected on a Bruker X8 Kappa Apex II diffractometer using Mo Ka radiation.
Crystal data, data collection and refinement parameters are summarized in Table EV1 (FKK5) and 
In silico experiments
A hybrid structure-based method has been adapted for modeling pharmacophore at PXR ligand binding pocket. Further, considering the dynamic nature of the protein, a conformational-based docking experiment has been conducted with identified FKK compounds at multiple sites in the PXR LBD (i.e., conventional ligand binding pocket, AF2 site as well as α8-pocket that was identified from earlier simulation study of PXR LBD 6 ). The methodology for pharmacophore modeling and PXR ensemble-based docking are described below in sections (a) and (b).
(a) Hybrid Structure Based (HSB) Method. The crystal structure of hPXR (pdb code: 1M13; PMID-12578355 ) was used for the modeling and docking studies. The crystal structure was prepared by removing any bound ligands or cofactors and hydrogen atoms were added and minimized to remove any steric clashes. The protein was then solvated in a 5Å of water at each direction of an atom with largest coordination in a box with simple point-charge water model in a periodic boundary condition.
The simulation parameter was performed by using CHARMM force field. All simulations were performed using NAMD program 7 . The full-system periodic electrostatic interaction was performed under Particle Mesh Ewald (PME) Sum method 8 . The temperature thermostats were a constant number, volume and temperature (NVT) steps 9,10 and constant pressure and temperature (NPT) equilibration and production MD 11, 12 . A constant temperature of 310 K and the continuous pressure was then used to screen our library of vendor available small molecules and 5 hit molecules that strictly obeyed the pharmacophore were docked into the LBD of PXR using docking program GOLD and the complexes were scored using goldscore and chemscore functions adopted in GOLD program. FKK999 and BAS451 were chosen for in vitro testing and based on the results, FKK999's core was chosen for further medicinal chemistry optimization. Based on the core structure, ten molecules designated as FKK1-10 were designed and synthesized. All FKK molecules were modeled and docked as described previously and FKK5 and FKK6 were the lead ranking molecules.
(b) Ensemble based-molecular docking to multiple sites. Ensemble-based molecular docking of ten FKK compounds were performed using GOLD suite version 5.5.0 (CCDC, Cambridge, UK) 14 .
GOLD uses a genetic algorithm (GA) to explore the conformational flexibility of the ligand and receptor side chains in the binding pocket. Thirty centroid conformations of apo hPXR generated using a RMSD-based clustering algorithm, obtained from previous work, were used for the docking 6 .
In all the protein conformations, water and ions were removed prior to docking. For the docking purpose, a binding site was defined by considering all atoms within 12 Å from the geometrical center of the docking site. For each of the 30 independent GA runs, a maximum number of 200 GA operations were performed. The docked complexes were ranked with goldscore and then rescored using a chemscore fitness function 14 . All the FKK compounds were docked at all the known binding sites in hPXR, including α8 pocket, to evaluate the relative affinity at different sites. The scoring functions account for the hydrogen bonding, vdW interactions and steric complementarity between the ligand and receptor. For each ligand, the best-ranked docked pose with corresponding chemscore was considered. Along with the scores, analysis was performed by visualizing the residues interacting with the ligand, using LigPlot + software 15 .
Immunoblotting. The cells were centrifuged (1500 rpm for 3 min), the medium was removed, and the pellet was resuspended in 150 µl of ice-cold lysis buffer (150 mM NaCl; 50 mM HEPES; 1% (v/v) Triton X-100; 5 mM EDTA; anti-protease cocktail, anti-phosphatase cocktail). The mixture was vortexed and incubated for 10 min on ice and then centrifuged (15000 rpm/13 min/4 °C). Supernatant was collected and the protein content was determined using the Bradford reagent. SDS-PAGE gels (10%) were run on a BioRad apparatus according to the general procedure followed by the protein absence. Nuclear protein fraction containing RXRs was obtained from purified nuclear pellet with a high ionic strength buffer containing 0.3 M KCl, with the addition of 1 mM MgCl2,10 mM Tris-HCl and freshly prepared 1 mM DTT at 0 o C for 60 minutes followed by ultracentrifugation at 135 000 x g for 60 minutes. Concentration of the prepared nuclear fraction of proteins was estimated by Lowry's method using bovine serum albumin as a standard.
Labeled[11,12-3 H(N)] 9-cis retinoic acid (9cRA) binding competition assay (RXR ligand binding) 19 . The assay on labeled 9cRA binding to nuclear proteins was performed in dark at 20 o C, in a high ionic strength buffer (0.3 M KCl, 1 mM MgCl2, 10 mM Tris-HCl buffer, and pH 7.0). Samples for total radioligand binding to its cognate nuclear receptors were incubated with 0.66 nM of [11, H(N)]9cRA (Canberra Packard, USA) and samples confirming displacement of bound radioligand from nuclear receptors were incubated either with 0.66 nM of [11, 
